Trial
NCT06237309
REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Regeneron Pharmaceuticals
Collaborators
—
Condition
Heart Failure
Intervention
REGN5381
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-14